Osteoporosis.
Canfield
G
G
Tennessee Department of Health, Nashville, USA.
D015502:Absorptiometry, Photon; D000368:Aged; D019386:Alendronate / Q000627:therapeutic use; D002116:Calcitonin / Q000627:therapeutic use; D002118:Calcium / Q000008:administration & dosage; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000517:prevention & control*; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use
D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride; C028815:salmon calcitonin; D002116:Calcitonin; D002118:Calcium; D019386:Alendronate